Dec. 5, 2017 -- The San Antonio Breast Cancer Symposium -- the annual international conference foucsed on breast cancer research -- is underway. Here's what's making news:
Adding the new drug Kisqali to treatment of advanced breast cancer can slow it's progression in young women, too. The drug is currently used to treat postmenopausal women with advanced breast cancer. Read more:
Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis. Read more:
Also, you can read conference coverage from Medscape, our site for health care professionals.